Researchers have come up with an ingenious means of engineering a virus so that it selectively replicates in and destroys tumor cells. Because the virus is unable to attack normal cells, it may prove useful as a supplement to traditional cancer treatments, which do not discriminate between normal and tumor cells and often cause debilitating side effects. The new type of adenoviruses, described by Richard Vile and coworkers in the July issue of Nature Biotechnology, replicates in cells with cancer-associated genetic mutations.
Vile and his team engineered into their virus a special type of mRNA ‘stability’ sequence that causes a gene (E1A) essential for viral replication to be degraded in normal cells, thus inhibiting reproduction of the virus. Because mRNA stability is improved in the presence of a protein called RAS - which is less abundant in normal cells, but common in certain cancer cells - the researchers hypothesized that their virus would, however, selectively replicate in and destroy tumor cells. Sure enough, when they injected the virus into tumors implanted in mice, it replicated and reduced tumor growth. The approach provides a step towards generating truly selective viral therapies against cancer.
Richard G. Vile
Tel: +1 507 284 9941
Also available online.
(C) Nature Biotechnology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...